1-10 of 10
Robert C. Seeger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells

Hong-Wei Wu, Michael A. Sheard, Jemily Malvar, G. Esteban Fernandez, Yves A. DeClerck, Laurence Blavier, Hiroyuki Shimada, Charles P. Theuer, Richard Sposto, Robert C. Seeger
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (15): 4761–4774.
DOI: https://doi.org/10.1158/1078-0432.CCR-18-3358
Published: 01 August 2019
View article
PDF
Includes: Supplementary data
Journal Articles

Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma

Wesley E. Barry, Jeremy R. Jackson, Grace E. Asuelime, Hong-Wei Wu, Jianping Sun, Zesheng Wan, Jemily Malvar, Michael A. Sheard, Larry Wang, Robert C. Seeger, Eugene S. Kim
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (1): 325–333.
DOI: https://doi.org/10.1158/1078-0432.CCR-18-1317
Published: 03 January 2019
View article
PDF
Includes: Supplementary data
Journal Articles

Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis

Araz Marachelian, Judith G. Villablanca, Cathy W. Liu, Betty Liu, Fariba Goodarzian, Hollie A. Lai, Hiroyuki Shimada, Hung C. Tran, Jaime A. Parra, Richard Gallego, Nora Bedrossian, Sabrina Young, Scarlett Czarnecki, Rebekah Kennedy, Brian D. Weiss, Kelly Goldsmith, Meaghan Granger, Katherine K. Matthay, Susan Groshen, Shahab Asgharzadeh, Richard Sposto, Robert C. Seeger
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (18): 5374–5383.
DOI: https://doi.org/10.1158/1078-0432.CCR-16-2647
Published: 14 September 2017
View article
PDF
Includes: Supplementary data
Journal Articles

TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells

Hung C. Tran, Zesheng Wan, Michael A. Sheard, Jianping Sun, Jeremy R. Jackson, Jemily Malvar, Yibing Xu, Larry Wang, Richard Sposto, Eugene S. Kim, Shahab Asgharzadeh, Robert C. Seeger
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (3): 804–813.
DOI: https://doi.org/10.1158/1078-0432.CCR-16-1743
Published: 31 January 2017
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract A30: NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome

Michael Hölzel, Sidong Huang, Jan Koster, Ingrid Ora, Arjan Lakeman, H. N. Caron, Tom Callens, Jing Xie, Wouter Nijkamp, Shahab Asgharzadeh, Robert C. Seeger, Ludwine Messiaen, Rogier Versteeg, Rene Bernards
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7_Supplement): A30.
DOI: https://doi.org/10.1158/1078-0432.TCME10-A30
Published: 02 February 2016
View article
Journal Articles

Growth and Activation of Natural Killer Cells Ex Vivo from Children with Neuroblastoma for Adoptive Cell Therapy

Yin Liu, Hong-Wei Wu, Michael A. Sheard, Richard Sposto, Srinivas S. Somanchi, Laurence J.N. Cooper, Dean A. Lee, Robert C. Seeger
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2013) 19 (8): 2132–2143.
DOI: https://doi.org/10.1158/1078-0432.CCR-12-1243
Published: 15 April 2013
View article
PDF
Includes: Supplementary data
Journal Articles

Molecular Characterization of the Pediatric Preclinical Testing Panel

Geoffrey Neale, Xiaoping Su, Christopher L. Morton, Doris Phelps, Richard Gorlick, Richard B. Lock, C. Patrick Reynolds, John M. Maris, Henry S. Friedman, Jeffrey Dome, Joseph Khoury, Timothy J. Triche, Robert C. Seeger, Richard Gilbertson, Javed Khan, Malcolm A. Smith, Peter J. Houghton
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (14): 4572–4583.
DOI: https://doi.org/10.1158/1078-0432.CCR-07-5090
Published: 15 July 2008
View article
PDF
Includes: Supplementary data
Journal Articles

De novo Identification of MIZ-1 (ZBTB17) Encoding a MYC-Interacting Zinc-Finger Protein as a New Favorable Neuroblastoma Gene

Naohiko Ikegaki, Takahiro Gotoh, Bing Kung, Justin S. Riceberg, David Y. Kim, Huaqing Zhao, Eric F. Rappaport, Sakeenah L. Hicks, Robert C. Seeger, Xao X. Tang
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (20): 6001–6009.
DOI: https://doi.org/10.1158/1078-0432.CCR-07-0071
Published: 18 October 2007
View article
PDF
Journal Articles

A Phase I Clinical Trial of the hu14.18-IL2 (EMD 273063) as a Treatment for Children with Refractory or Recurrent Neuroblastoma and Melanoma: a Study of the Children's Oncology Group

Kaci L. Osenga, Jacquelyn A. Hank, Mark R. Albertini, Jacek Gan, Adam G. Sternberg, Jens Eickhoff, Robert C. Seeger, Katherine K. Matthay, C. Patrick Reynolds, Clare Twist, Mark Krailo, Peter C. Adamson, Ralph A. Reisfeld, Stephen D. Gillies, Paul M. Sondel
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (6): 1750–1759.
DOI: https://doi.org/10.1158/1078-0432.CCR-05-2000
Published: 21 March 2006
View article
PDF
Journal Articles

Expression of Protein Gene Product 9.5 and Tyrosine Hydroxylase in Childhood Small Round Cell Tumors

Yinglin Wang, Peggy Einhorn, Timothy J. Triche, Robert C. Seeger, C. Patrick Reynolds
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (2): 551–558.
Published: 01 February 2000
View article
PDF